Chronic smoking and the BOLD response to a visual activation task and a breath hold task in patients with schizophrenia and healthy controls

NeuroImage

Volumn 40, Issue 3, 2008, Pages 1181-1194

  Friedman, Lee ^a   Turner, Jessica A ^b   Stern, Hal ^c   Mathalon, Daniel H ^d   Trondsen, Liv C ^b   Potkin, Steven G ^b  

^a University of California Irvine ^*  (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c Ringgold Standard Institution Informatics   (United States)

^d UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; BREATH HOLDING; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FUNCTIONAL MAGNETIC RESONANCE IMAGING; GRAY MATTER; HUMAN; MALE; NEUROIMAGING; OXYGEN BLOOD LEVEL; PRIORITY JOURNAL; SCHIZOPHRENIA; SMOKING; TASK PERFORMANCE; VISUAL CORTEX; VISUAL STIMULATION;

ADULT; AGING; CEREBROVASCULAR CIRCULATION; FEMALE; HEAD MOVEMENTS; HUMANS; IMAGE PROCESSING, COMPUTER-ASSISTED; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; OXYGEN; PHOTIC STIMULATION; RESPIRATORY MECHANICS; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SMOKING; VISUAL CORTEX; VISUAL PERCEPTION;

EID: 40849102525     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2007.12.040     Document Type: Article

References (79)

1. Andreasen N.C. The Scale for the Assessment of Negative Symptoms (SANS): conceptual and theoretical foundations. Br. J. Psychiatry Suppl 7 (1989) 49-58
2. Andreasen N.C., Flaum M., Swayze II V.W., Tyrrell G., and Arndt S. Positive and negative symptoms in schizophrenia. A critical reappraisal. Arch. Gen. Psychiatry 47 7 (1990) 615-621
3. Astrup P. Carbon monoxide, smoking and atherosclerosis. Postgrad. Med. J. 49 576 (1973) 697-706
4. Bedwell J.S., Miller L.S., Brown J.M., and Yanasak N.E. Schizophrenia and red light: fMRI evidence for a novel biobehavioral marker. Int. J. Neurosci. 116 8 (2006) 881-894
5. Behzadi Y., and Liu T.T. An arteriolar compliance model of the cerebral blood flow response to neural stimulus. Neuroimage 25 4 (2005) 1100-1111
6. Braff D.L. Information processing and attention dysfunctions in schizophrenia. Schizophr. Bull. 19 2 (1993) 233-259
7. Brody A.L. Functional brain imaging of tobacco use and dependence. J. Psychiatr. Res. 40 5 (2006) 404-418
8. Buxton R.B. Introduction to Functional Magnetic Resonance Imaging: Principles and Techniques (2002), Camebridge University Press, Cambridge 523 p
9. Buxton R.B., Wong E.C., and Frank L.R. Dynamics of blood flow and oxygenation changes during brain activation: the balloon model. Magn. Reson. Med. 39 6 (1998) 855-864 Jun
10. Chen H.I. Effects of chronic smoking on respiratory muscle function. Chin. J. Physiol. 31 1 (1988) 53-62
11. Cicchetti D.V., and Sparrow S.A. Developing criteria for establishing interrater reliability of specific items: applications to assessment of adaptive behavior. Am. J. Ment. Defic. 86 2 (1981) 127-137
12. Clark K.D., Wardrobe-Wong N., Elliott J.J., Gill P.T., Tait N.P., and Snashall P.D. Cigarette smoke inhalation and lung damage in smoking volunteers. Eur. Respir. J. 12 2 (1998) 395-399
13. Cohen E.R., Ugurbil K., and Kim S.G. Effect of basal conditions on the magnitude and dynamics of the blood oxygenation level-dependent fMRI response. J. Cereb. Blood Flow Metab. 22 9 (2002) 1042-1053
14. Cooke J.P., and Bitterman H. Nicotine and angiogenesis: a new paradigm for tobacco-related diseases. Ann. Med. 36 1 (2004) 33-40
15. Cox R.W. AFNI: software for analysis and visualization of functional magnetic resonance neuroimages. Comput. Biomed. Res. 29 3 (1996) 162-173
16. de Leon J., and Diaz F.J. A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors. Schizophr. Res. 76 2-3 (2005) 135-157
17. Durazzo T.C., and Meyerhoff D.J. Neurobiological and neurocognitive effects of chronic cigarette smoking and alcoholism. Front. Biosci. 12 (2007) 4079-4100
18. Eliasson B. Cigarette smoking and diabetes. Prog. Cardiovasc. Dis. 45 5 (2003) 405-413
19. Eyler L.T., Olsen R.K., Nayak G.V., Mirzakhanian H., Brown G.G., and Jeste D.V. Brain response correlates of decisional capacity in schizophrenia: a preliminary FMRI study. J. Neuropsychiatry Clin. Neurosci. 19 2 (2007) 137-144
20. First M.B., Spitzer R.L., Gibbon M., and Williams J.B.W. Structured Clinical Interview for DSM-IV-TR Axis I Disorders - Patient Edition (SCID-I/P, 11/2002 revision). Biometrics Research Department, New York State Psychiatric Institute (2002)
21. Fischer H., Sandblom J., Gavazzeni J., Fransson P., Wright C.I., and Backman L. Age-differential patterns of brain activation during perception of angry faces. Neurosci. Lett. 386 2 (2005) 99-104
22. Ford J.M., Johnson M.B., Whitfield S.L., Faustman W.O., and Mathalon D.H. Delayed hemodynamic responses in schizophrenia. Neuroimage 26 3 (2005) 922-931
23. Friedman L., Stern H., Brown G.G., Mathalon D.H., Turner J., Glover G.H., Gollub R.L., Lauriello J., Lim K.O., Cannon T., Greve D.N., Bockholt H.J., Belger A., Mueller B., Doty M.J., He J., Wells W., Smyth P., Pieper S., Kim S., Kubicki M., Vangel M., and Potkin S.G. Test-retest and between-site reliability in a multicenter fMRI study. Hum. Brain Mapp. (2007) Electronic publication
24. Friston K.J., Mechelli A., Turner R., and Price C.J. Nonlinear responses in fMRI: the Balloon model, Volterra kernels, and other hemodynamics. Neuroimage 12 4 (2000) 466-477
25. Gustard S., Williams E.J., Hall L.D., Pickard J.D., and Carpenter T.A. Influence of baseline hematocrit on between-subject BOLD signal change using gradient echo and asymmetric spin echo EPI. Magn. Reson. Imaging 21 6 (2003) 599-607
26. Hamzei F., Knab R., Weiller C., and Rother J. The influence of extra- and intracranial artery disease on the BOLD signal in FMRI. Neuroimage 20 2 (2003) 1393-1399
27. Handwerker D.A., Gazzaley A., Inglis B.A., D, and Esposito M. Reducing vascular variability of fMRI data across aging populations using a breathholding task. Hum. Brain Mapp. 28 9 (2007) 846-859
28. Harrison B.J., Yucel M., Pujol J., and Pantelis C. Task-induced deactivation of midline cortical regions in schizophrenia assessed with fMRI. Schizophr. Res. 91 1-3 (2007) 82-86
29. Hennekens C.H., Hennekens A.R., Hollar D., and Casey D.E. Schizophrenia and increased risks of cardiovascular disease. Am. Heart J. 150 6 (2005) 1115-1121
30. Hesselmann V., Zaro Weber O., Wedekind C., Krings T., Schulte O., Kugel H., Krug B., Klug N., and Lackner K.J. Age related signal decrease in functional magnetic resonance imaging during motor stimulation in humans. Neurosci. Lett. 308 3 (2001) 141-144
31. Huettel S.A., and McCarthy G. The effects of single-trial averaging upon the spatial extent of fMRI activation. Neuroreport 12 11 (2001) 2411-2416
32. Huettel S.A., Singerman J.D., and McCarthy G. The effects of aging upon the hemodynamic response measured by functional MRI. Neuroimage 13 1 (2001) 161-175
33. Isager H., and Hagerup L. Relationship between cigarette smoking and high packed cell volume and haemoglobin levels. Scand. J. Haematol. 8 4 (1971) 241-244
34. Isaka Y., Ashida K., Imaizumi M., and Abe H. Effect of chronic smoking on regional cerebral blood flow in asymptomatic individuals. Yakubutsu, Seishin, Kodo 13 3 (1993) 191-198
35. Jacobsen L.K., Mencl W.E., Constable R.T., Westerveld M., and Pugh K.R. Impact of smoking abstinence on working memory neurocircuitry in adolescent daily tobacco smokers. Psychopharmacology (Berl) 193 4 (2007) 557-566
36. Karlsgodt K.H., Glahn D.C., van Erp T.G., Therman S., Huttunen M., Manninen M., Kaprio J., Cohen M.S., Lonnqvist J., and Cannon T.D. The relationship between performance and fMRI signal during working memory in patients with schizophrenia, unaffected co-twins, and control subjects. Schizophr. Res. 89 1-3 (2007) 191-197
37. Kindermann S.S., Karimi A., Symonds L., Brown G.G., and Jeste D.V. Review of functional magnetic resonance imaging in schizophrenia. Schizophr. Res. 27 2-3 (1997) 143-156
38. Kochar MS, Bindra RS. (1996): The additive effects of smoking and hypertension. More reasons to help your patients kick the habit. Postgrad. Med. 100(5):147-8, 151-4, 159-60.
39. Kwee I.L., and Nakada T. Dorsolateral prefrontal lobe activation declines significantly with age-functional NIRS study. J. Neurol. 250 5 (2003) 525-529
40. Lamar M., Yousem D.M., and Resnick S.M. Age differences in orbitofrontal activation: an fMRI investigation of delayed match and nonmatch to sample. Neuroimage 21 4 (2004) 1368-1376
41. Lawrence N.S., Ross T.J., and Stein E.A. Cognitive mechanisms of nicotine on visual attention. Neuron 36 3 (2002) 539-548
42. Leonard S., Adler L.E., Benhammou K., Berger R., Breese C.R., Drebing C., Gault J., Lee M.J., Logel J., Olincy A., Ross R.G., Stevens K., Sullivan B., Vianzon R., Virnich D.E., Waldo M., Walton K., and Freedman R. Smoking and mental illness. Pharmacol. Biochem. Behav. 70 4 (2001) 561-570
43. Lepage M., Montoya A., Pelletier M., Achim A.M., Menear M., and Lal S. Associative memory encoding and recognition in schizophrenia: an event-related fMRI study. Biol. Psychiatry 60 11 (2006) 1215-1223
44. Levin J.M., Frederick Bde B., Ross M.H., Fox J.F., von Rosenberg H.L., Kaufman M.J., Lange N., Mendelson J.H., Cohen B.M., and Renshaw P.F. Influence of baseline hematocrit and hemodilution on BOLD fMRI activation. Magn. Reson. Imaging 19 8 (2001) 1055-1062
45. Li X., Branch C.A., Bertisch H.C., Brown K., Szulc K.U., Ardekani B.A., and DeLisi L.E. An fMRI study of language processing in people at high genetic risk for schizophrenia. Schizophr. Res. 91 1-3 (2007) 62-72
46. Liddle P.F., Laurens K.R., Kiehl K.A., and Ngan E.T. Abnormal function of the brain system supporting motivated attention in medicated patients with schizophrenia: an fMRI study. Psychol. Med. 36 8 (2006) 1097-1108
47. Liu T.T., Behzadi Y., Restom K., Uludag K., Lu K., Buracas G.T., Dubowitz D.J., and Buxton R.B. Caffeine alters the temporal dynamics of the visual BOLD response. Neuroimage 23 4 (2004) 1402-1413
48. Lowe G.D., Drummond M.M., Forbes C.D., and Barbenel J.C. The effects of age and cigarette-smoking on blood and plasma viscosity in men. Scott. Med. J. 25 1 (1980) 13-17
49. Lu H., Zhao C., and Lewis-Amezcua K. Baseline cerebral venous oxygenation determines response amplitudes: physiologic basis for inter-subject variations in fMRI results. 13th Annual Meeting of the Organization for Human Brain Mapping. Chicago, IL USA (2007)
50. Marder S.R., Essock S.M., Miller A.L., Buchanan R.W., Casey D.E., Davis J.M., Kane J.M., Lieberman J.A., Schooler N.R., Covell N., Stroup S., Weissman E.M., Wirshing D.A., Hall C.S., Pogach L., Pi-Sunyer X., Bigger Jr. J.T., Friedman A., Kleinberg D., Yevich S.J., Davis B., and Shon S. Physical health monitoring of patients with schizophrenia. Am. J. Psychiatry 161 8 (2004) 1334-1349
51. Marjoram D., Job D.E., Whalley H.C., Gountouna V.E., McIntosh A.M., Simonotto E., Cunningham-Owens D., Johnstone E.C., and Lawrie S. A visual joke fMRI investigation into theory of mind and enhanced risk of schizophrenia. Neuroimage 31 4 (2006) 1850-1858
52. Meyer J.S., Gotoh F., Takagi Y., and Kakimi R. Cerebral hemodynamics, blood gases, and electrolytes during breath-holding and the Valsalva maneuver. Circulation 33 5 Suppl (1966) II35-II 48
53. Miller G.A., and Chapman J.P. Misunderstanding analysis of covariance. J. Abnorm. Psychology 110 1 (2001) 40-48
54. Mustard J.F. Cigarette smoking, atherosclerosis and its clinical complications. Can. J. Public Health 72 6 (1981) 385-388
55. Nagel M., Sprenger A., Nitschke M., Zapf S., Heide W., Binkofski F., and Lencer R. Different extraretinal neuronal mechanisms of smooth pursuit eye movements in schizophrenia: an fMRI study. Neuroimage 34 1 (2007) 300-309
56. Olincy A., Young D.A., and Freedman R. Increased levels of the nicotine metabolite cotinine in schizophrenic smokers compared to other smokers. Biol. Psychiatry 42 1 (1997) 1-5
57. Roc A.C., Wang J., Ances B.M., Liebeskind D.S., Kasner S.E., and Detre J.A. Altered hemodynamics and regional cerebral blood flow in patients with hemodynamically significant stenoses. Stroke 37 2 (2006) 382-387
58. 2 inhalation. J. Am. Geriatr. Soc. 32 6 (1984) 415-420
59. Ross M.H., Yurgelun-Todd D.A., Renshaw P.F., Maas L.C., Mendelson J.H., Mello N.K., Cohen B.M., and Levin J.M. Age-related reduction in functional MRI response to photic stimulation. Neurology 48 1 (1997) 173-176
60. Saad Z.S., Ropella K.M., DeYoe E.A., and Bandettini P.A. The spatial extent of the BOLD response. Neuroimage 19 1 (2003) 132-144
61. Schlosser R.G., Nenadic I., Wagner G., Gullmar D., von Consbruch K., Kohler S., Schultz C.C., Koch K., Fitzek C., Matthews P.M., Reichenbach J.R., and Sauer H. White matter abnormalities and brain activation in schizophrenia: a combined DTI and fMRI study. Schizophr. Res. 89 1-3 (2007) 1-11
62. Schneider F., Habel U., Reske M., Kellermann T., Stocker T., Shah N.J., Zilles K., Braus D.F., Schmitt A., Schlosser R., Wagner M., Frommann I., Kircher T., Rapp A., Meisenzahl E., Ufer S., Ruhrmann S., Thienel R., Sauer H., Henn F.A., and Gaebel W. Neural correlates of working memory dysfunction in first-episode schizophrenia patients: an fMRI multi-center study. Schizophr. Res. 89 1-3 (2007) 198-210
63. Shrout P.E., and Fleiss J.L. Intraclass correlations: uses in assessing rater reliability. Psychol. Bull. 86 2 (1979) 420-428
64. Suslow T., and Arolt V. Disorders of early information processing and vigilance as vulnerability markers for schizophrenia. Fortschr. Neurol. Psychiatr. 64 3 (1996) 90-104
65. Thermenos H.W., Seidman L.J., Poldrack R.A., Peace N.K., Koch J.K., Faraone S.V., and Tsuang M.T. Elaborative verbal encoding and altered anterior parahippocampal activation in adolescents and young adults at genetic risk for schizophrenia using FMRI. Biol. Psychiatry 61 4 (2007) 564-574
66. Thomason M.E., Burrows B.E., Gabrieli J.D., and Glover G.H. Breath holding reveals differences in fMRI BOLD signal in children and adults. Neuroimage 25 3 (2005) 824-837
67. Thomason M.E., Foland L.C., and Glover G.H. Calibration of BOLD fMRI using breath holding reduces group variance during a cognitive task. Hum. Brain Mapp. 28 1 (2007) 59-68
68. Tost H., Ende G., Ruf M., Henn F.A., and Meyer-Lindenberg A. Functional imaging research in schizophrenia. Int. Rev. Neurobiol. 67 (2005) 95-118
69. Tu P.C., Yang T.H., Kuo W.J., Hsieh J.C., and Su T.P. Neural correlates of antisaccade deficits in schizophrenia, an fMRI study. J. Psychiatr. Res. 40 7 (2006) 606-612
70. Walter H., Vasic N., Hose A., Spitzer M., and Wolf R.C. Working memory dysfunction in schizophrenia compared to healthy controls and patients with depression: evidence from event-related fMRI. Neuroimage 35 4 (2007) 1551-1561
71. Wessels A.M., Rombouts S.A., Simsek S., Kuijer J.P., Kostense P.J., Barkhof F., Scheltens P., Snoek F.J., and Heine R.J. Microvascular disease in type 1 diabetes alters brain activation: a functional magnetic resonance imaging study. Diabetes 55 2 (2006) 334-340
72. Whisnant J.P., Homer D., Ingall T.J., Baker Jr. H.L., O, Fallon W.M., and Wievers D.O. Duration of cigarette smoking is the strongest predictor of severe extracranial carotid artery atherosclerosis. Stroke 21 5 (1990) 707-714
73. Whitehead T.P., Robinson D., Allaway S.L., and Hale A.C. The effects of cigarette smoking and alcohol consumption on blood haemoglobin, erythrocytes and leucocytes: a dose related study on male subjects. Clin. Lab. Haematol. 17 2 (1995) 131-138
74. Whyte M.C., Whalley H.C., Simonotto E., Flett S., Shillcock R., Marshall I., Goddard N.H., Johnstone E.C., and Lawrie S.M. Event-related fMRI of word classification and successful word recognition in subjects at genetically enhanced risk of schizophrenia. Psychol. Med. 36 10 (2006) 1427-1439
75. Wolff A.L., and O'Driscoll G.A. Motor deficits and schizophrenia: the evidence from neuroleptic-naive patients and populations at risk. J. Psychiatry Neurosci. 24 4 (1999) 304-314
76. Worsley K.J., Liao C.H., Aston J., Petre V., Duncan G.H., Morales F., and Evans A.C. A general statistical analysis for fMRI data. Neuroimage 15 1 (2002) 1-15
77. Xu J., Mendrek A., Cohen M.S., Monterosso J., Simon S., Jarvik M., Olmstead R., Brody A.L., Ernst M., and London E.D. Effect of cigarette smoking on prefrontal cortical function in nondeprived smokers performing the Stroop Task. Neuropsychopharmacology 32 6 (2007) 1421-1428
78. Yoon J.H., D'Esposito M., and Carter C.S. Preserved function of the fusiform face area in schizophrenia as revealed by fMRI. Psychiatry. Res. 148 2-3 (2006) 205-216
79. Zarahn E., Rakitin B., Abela D., Flynn J., and Stern Y. Age-related changes in brain activation during a delayed item recognition task. Neurobiol. Aging 28 (2006) 784-798